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Pregnant, and Gestational Diabetic Women: 
Erythrocytes Osmotic Fragility Profiles
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Abstract
Background: Inconsistent reports are available in the literature 
regarding the oxidative status and antioxidant capacity during the 
pathogenesis of gestational diabetes. Present study was aimed to 
evaluate oxidative stress during the development of gestational dia-
betes and to evaluate antioxidant capability in non-pregnant (con-
trol), pregnant and gestational diabetics.
Methods: The study consisted of non-pregnant, healthy pregnant 
and patients suffering from gestational diabetes mellitus (GDM). 
Each group consisted of 23 women. We compared their oxidative 
and anti-oxidative system in blood. Their blood malondialdehyde 
(MDA) and antioxidant vitamins (C, E, A) were determined and 
compared to evaluate the oxidative status and anti-oxidative capac-
ity of these groups. We have also compared the osmotic fragility 
profiles of the erythrocytes of these groups.
Results: Plasma MDA content in pregnant was significantly higher 
compared to non-pregnant (p < 0.001, 67.5%) and even in gesta-
tional diabetics; its value was found significantly further elevated (p 
= 0.001, 13.8%) compared to healthy pregnant. There was signifi-
cant decline (p < 0.001, 41.9%) in the level of vitamin C in pregnant 
as compared to non-pregnant. Although in GDM the decrease was 
significant (p = 0.025, 20.6%) but comparatively lesser when com-
pared to healthy pregnant. Vitamin E showed the increase of 9.6% 
during pregnancy, although this alteration was non-significant (p = 
0.09), but the level was found to decline significantly (p < 0.001, 
25.5%) in GDM compared to pregnant group. Vitamin A contents 
were also decreased in pregnant (p = 0.002, 17.4%) compared to 
non-pregnant and in GDM (p = 0.012, 11.2%) compared to preg-
nant group. Osmotic fragility (O.F.) profiles showed insignificant 
(p = 0.325) enhanced mean erythrocyte fragility (MEF) in pregnant 
but this increase was significant (p = 0.003) in case of GDM. The 
O.F. profiles of pregnant and GDM erythrocytes got shifted to the 
right side of the control one.
Conclusions: Our findings indicate highly enhanced lipid peroxi-
dation and significant depletion in antioxidant capacity during the 
development of gestational diabetes, and these alterations are not 
the cause but the consequence of GDM. However, further studies 
are warranted to examine a wider range of biochemical parameters 
to evaluate the potential risks of oxidative damage in GDM.
Keywords: Gestational diabetes; Oxidative stress; Anti-oxidants; 
Vitamins C, E, A; Osmotic fragility; Non-pregnant; Pregnant; GDM
Introduction
Gestational  diabetes  mellitus  (GDM)  is  a  heterogeneous 
disorder characterized by intolerance to carbohydrates and 
hyperglycemia  in  varied  degrees  of  intensity,  with  onset 
or first diagnosis during pregnancy [1]. The pregnancy is 
a physiological situation of insulin resistance; therefore, it 
may be the first moment in a woman’s life to test her capac-
ity to respond to a physiological stress and to detect those at 
greater risk of developing diabetes in the future. Oxidative 
stress (OS) due to elevated reactive oxygen species (ROS) 
has been clearly linked to type 2 diabetes mellitus, however, 
limited and inconsistent data are available on the involve-
ment of OS in GDM, a disease of similar pathophysiology. 
Women with GDM present a higher probability of develop-
ing higher risk markers of cardiovascular disease expressed 
as higher levels of lipid peroxides and descending levels of 
antioxidants. Further, that high blood glucose level induces 
oxidative stress and decreases antioxidant defenses. Fetuses 
born to mothers with gestational diabetes are at increased 
risk of developing respiratory distress, fetal macrosomia, fe-
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tal anomalies and platelet hyperaggregability. In a healthy 
body, ROS and antioxidants remain in balance. The OS oc-
curs when this balance is shifted towards an overabundance 
of ROS. And OS results from an imbalance between pro-oxi-
dants (free radical species) and the body’s scavenging ability 
(antioxidants). The exact pro-oxidant and antioxidant status 
in gestational diabetes is still not clear. The present study 
addresses the possibility of lipoperoxidation and antioxidant 
activity in the blood of healthy non-pregnant, pregnant and 
gestational diabetic women. 
A process that has been proposed as a common biochem-
ical connection between chronic hyperglycemia and several 
physiologic functions relevant to diabetic complications is 
excessive non-enzymatic attachment of glucose to proteins 
[2]. Excessive formation of glycosylated proteins has been 
associated with alterations in the uptake of low-density lipo-
proteins [2] and with vascular damage mediated by the regu-
lation of free radical formation [3]. Enhanced glycosylation 
by elevated glucose concentration may induce the formation 
of oxygen derived free radicals through protein glycosyl-
ation, which releases early and late glycosylated end prod-
ucts, contributing to enhancement of oxidative stress seen 
in diabetes [4]. Human erythrocytes are perhaps the cells 
most exposed to peroxidation damage by free radicals. The 
mechanisms by which the erythrocyte defends itself against 
oxidative damage are very efficient and are located in both 
cytosol and membrane domains. The membrane itself con-
tains only vitamin E, the major lipid soluble chain breaking 
antioxidant [5]. 
Recent studies have examined the effect of intake of vi-
tamins E and C, nutrients known to have antioxidant proper-
ties in vivo, on GHb concentrations in human subjects [6, 7]. 
Ceriello et al [6] found that large doses of tocopherol orally 
administered to individuals with diabetes lowered GHb con-
centrations. Davie et al [7] observed a similar pattern when 
large doses of ascorbic acid were orally administered to non-
diabetic subjects. The mechanisms for this reduction in non-
enzymatic glycosylation are not known but may be related to 
these nutrients’ antioxidant properties or, for ascorbic acid, 
to a competition with glucose for protein binding. However, 
there is no consensus on the pathophysiological events un-
derlying oxidative stress in diabetic patients, especially in 
pregnancy (GDM). Even, there is no consistency in the vari-
ous reports regarding the levels of MDA contents and vita-
mins A, E and C in the plasma/blood of gestational diabetics 
as compared to the normal pregnant [8-15]. So far available 
data regarding pro–oxidant and antioxidant status in gesta-
tional diabetes are insufficient and controversial. In an ear-
lier study, significant increase in lipid peroxidation level in 
diabetic pregnancy as compared to normal pregnancy was 
reported [16]. In contrast to this, an another study in early 
diabetic pregnancy found no evidence of greater lipid perox-
idation in pregnant diabetics as compared to normal pregnant 
women, and total antioxidant capacity was also reported to 
be similar in both the groups [13].
Literature reveals very little information on erythrocyte 
osmotic fragility whereas this parameter is also significant 
to evaluate pathophysiological status of gestational diabetes. 
In 1987, increased osmotic fragility has been reported by us 
in the blood of diabetic patients which returned to normalcy 
after insulin treatment [17]. Our earlier report, that the en-
hanced oxidative stress results in increased osmotic fragility 
[18], tempted us to include osmotic fragility parameter also 
in the present study. Furthermore, there is a recent report in 
2009 demonstrating that osmotic fragility of erythrocyte was 
greater in type 2 diabetic subjects compared to non-diabetic 
controls [19]. There are reports of no change in erythrocyte 
deformability  [20,  21]  whereas  other  have  reported  de-
creased deformability and increased red cell osmotic fragil-




EDTA, Thiobarbituric acid (TBA) and butylated hydroxy-
toluene (BHT) were from Sigma Chemical Company (St. 
Louis, MO, USA). Other chemicals of analytical grade were 
obtained from E. Merck (Mumbai, India), BDH or SISCO 
Chemicals (Mumbai, India).
Subjects
The  patients  in  the  present  study  included  non-pregnant 
women (n = 23), normal healthy pregnant women (n = 23), 
gestational diabetic women (n = 23) admitted to the hospi-
tal who had been or not under regular care, and also those 
who were referred from private sectors or primary health 
centers. All the participants were within the age range of 21 
- 32 years and the pregnant women were between 33 and 37 
weeks of pregnancy. Body height and weight of the subjects 
were measured to calculate their body mass index (BMI). 
Women were diagnosed with GDM if two or more of the 
100 gram oral glucose tolerance test (OGTT) glucose levels 
exceeded the American Diabetes Association (ADA) criteria 
[22]: fasting: ≥ 95mg/dl (5.3 mmol/L); one hour: ≥ 180mg/dl 
(10.0 mmol/L); two hours: ≥ 155mg/dl (8.6 mmol/L) ; three 
hours: ≥140mg/dl (7.8 mmol/L). The present study was car-
ried out with the prior approval of the local ethical commit-
tee. All the patients mentioned above gave their consent in 
writing, and the objectives of the study were fully explained 
to them in detail prior to taking consent. None of the par-
ticipants had a family history of diabetes mellitus, hyperten-
sion, or obesity. Patients suffering from disease of any origin 
other than gestational diabetes were excluded from the study. 
Three groups were not having any additional supplement of 
vitamins.
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Sample collection
Blood samples were collected from the mothers at delivery. 
In each case, 10 mL blood were drawn into a sodium heparin 
vacutainer tube for separating plasma and stored at 4oC until 
processed. All samples were processed within 20 hours of 
sampling and plasma samples were stored at -70oC until re-
quired for vitamin analyses. Before storage, an equal volume 
of metaphosphoric acid (10%) was added to plasma samples 
designated for vitamin C analysis in order to deproteinize the 
plasma and stabilize the vitamin C content.  
Isolation of erythrocytes and hemolysate preparation
The blood samples were centrifuged at 1000 g for 15 min 
at 4°C and the isolated red cells were washed 4 - 5 times 
with 0.154 M NaCl to remove plasma and buffy coat. After 
final wash, the required packed red blood cells were lysed 
by hypotonic shock and different dilutions were used as he-
molysate.
Osmotic fragility protocol
Osmotic fragility (O.F.) experiments were performed fol-
lowing the method of Dacie and Lewis [23]. The NaCl con-
centration of 50% hemolysis was taken as a measure of mean 
erythrocyte fragility (MEF). Color measurement was made 
using Systronics colorimeter.
Hemoglobin estimation
The method of Tentori and Salvati [24] was employed for 
hemoglobin estimation. Hemoglobin content of the sample 
was measured using cyanmethemoglobin method by mixing 
20 μL of blood and 5 mL of (1:251 diluted) ferricyanide re-
agent [K3Fe(CN)6, 200 mg; KCN, 50 mg; K2HPO4, 140 mg; 
appropriate amount of detergent Triton X-100 dissolved and 
raised to one liter, pH 7.4] and allowing to stand for at least 3 
min. Afterwards, absorbance was read at 540 nm using water 
as blank.
Estimation of lipid peroxidation
Lipid peroxidation was quantified following the method of 
Jain et al [25]. Packed red cells (0.2 mL) were used for the 
quantification of malondialdehyde (MDA) as thiobarbituric 
acid reactive substances (TBARS). Aliquots of 0.2 mL were 
mixed thoroughly with 0.8 mL of phosphate-buffered saline 
(8.1 g NaCl, 2.302 g Na2HPO4, and 0.194 g NaH2PO4/L, pH 
7.4) and 25 μL of butylatedhydroxytoluene (BHT, 88 mg/10 
mL absolute alcohol) solution. After adding 0.5 mL of 30% 
trichloroacetic acid, the samples were vortexed and allowed 
to stand in ice for 2 h, and then centrifuged at 2000xg at 25oC 
for 15 min. One milliliter of supernatant was mixed with 75 
μL of 0.1 M EDTA and 250 μL of 1% thiobarbituric acid in 
0.05 M NaOH and placed on boiling water for 15 min. After 
cooling to room temperature, absorbance was measured at 
532 nm and 600 nm. For evaluation of MDA, absorbance at 
600 nm was subtracted from absorbance at 532 nm. BHT, 
an antioxidant, is added to prevent MDA formation during 
assay, which could result in falsely elevated TBA reactiv-
ity. The addition of BHT to standard MDA did not affect 
the color development with TBA. MDA content is expressed 
as nmol/gHb. Linearity established for MDA concentrations 
was ranging from 0.2 to 6 μmol/L, accuracy/recovery per-
centage was 90-95%, precision coefficient of variation (CV) 
values were 5% (intraday) and 12% (inter-days). LOD (limit 
of detection) and LOQ (limit of quantification) were 0.05 
μmol/L and 0.09 μmol/L, respectively. 
Estimation of plasma vitamin C  
Vitamin C concentrations were determined in plasma using 
the method of Jagota and Dani [26]. Plasma (0.2 mL) was 
precipitated on ice with 0.8 mL of 10% trichloroacetic acid 
for 5 minutes and then centrifuged at 1000xg for 5 min. A 
total of 0.5 mL of the supernatant was diluted with distilled 
water to the volume of 2 mL. Folin-Ciocalteau’s solution 
(200 μL) diluted to 2 mL with distilled water, was added to 
the samples and mixed immediately. After 10 min, the absor-
bance at 760 nm of the blue color developed was measured 
spectrophotometrically. The sample values were compared 
with values of standard samples of ascorbic acid prepared in 
distilled water. Linearity established for vitamin C concen-
trations was ranging from 2 to 40 μg/mL, accuracy/recovery 
percentage was 93-100%, precision CV values were 2.5% 
(intraday) and 4.5% (inter-days). LOD and LOQ were 0.5 
mg/L and 1 mg/L, respectively.
Estimation of plasma vitamin A  
 
Plasma vitamin A was estimated following the procedure 
of Sobel and Snow [27]. One milliliter of 95% ethanol was 
added to 1 mL plasma, the contents were mixed by tapping; 
2 mL analytical reagent petroleum ether was added and the 
tube was shaken for 10 min. After shaking, the tube was cen-
trifuged for about 30 seconds. The supernatant petroleum 
ether was aspirated and placed in a test tube. With another 2 
mL of the petroleum ether, and shaking for only 5 min, the 
extraction procedure was repeated. The extract was evapo-
rated to dryness by placing the tube in a 40-50oC water bath 
and running a stream of nitrogen over it. Analytical reagent 
grade chloroform (1 mL) was added to bring the dried ex-
tract into solution. Four milliliter of Glycerol dichlorohydrin 
(GDH) was added. The chloroform solution and the GDH 
were mixed and after 2 min, absorption was measured at 550 
nm against a blank consisting of 4 mL of GDH and 1 mL of 
chloroform. Linearity established for vitamin A concentra-
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tions was ranging from 50 to 1200 μg/L, accuracy/recovery 
percentage was 87-96%, precision CV values were 7.5% (in-
traday) and 10.8% (inter-days). LOD and LOQ were 9 μg/L 
and 20 μg/L, respectively.
Estimation of plasma vitamin E  
A volume of 0.8 mL of plasma was pipetted into test tube 
and an equal volume of purified absolute ethanol was added 
to the tube for protein precipitation. The contents were im-
mediately mixed with a vortex mixer, with 0.8 mL of xylene 
added, and the test tube was mixed for 30 s and centrifuged 
for 5 - 10 min at 1000xg. After centrifugation, the upper xy-
lene layer containing extracted tocopherol was transferred 
to a small tube using a medicinal dropper. The tubes were 
covered with parafilm to avoid evaporation. Added 0.4 mL 
of plasma-xylene extract to the test tube containing 0.2 mL 
of 4, 7-diphenyl-1, 10-phenanthroline (bathophenanthroline, 
BA). A volume of 0.2 mL ferric chloride was added, fol-
lowed by 0.2 mL of orthophosphoric acid. The contents of 
the tube were mixed thoroughly using a vortex mixer after 
every addition of reagents. The order of reagent addition 
is critical. Absorbance was read in the spectrophotometer 
at 536 nm after setting the instrument to zero absorbance 
with a blank (prepared by using 0.4 mL xylene instead of 
plasma-xylene extract). Linearity established for vitamin A 
concentrations was ranging from 0.8 to 20 mg/L, accuracy/
recovery percentage was 85-90%, precision CV values were 
6% (intraday) and 11% (inter-days). LOD and LOQ were 0.4 
mg/L and 0.6 mg/L, respectively. Vitamin E contents were 
expressed as mol/L [28].
 
Statistical analysis 
SPSS version 15.0 for Windows (SPSS Inc., Chicago, IL, 
USA) software package was used to analyze the data of vari-
ous parameters. The results were statistically analyzed using 
Student’s t-test. The t-test statistical significance was set at 




The clinical characteristics of the different groups of patients 
are shown in Table 1. All the patients were within the age 
range of 21 - 32 years and were classified into three groups: 
Non-pregnant control group, pregnant group and gestational 
diabetics group. 
The oxidative status was evaluated in terms of MDA 
contents in all the patients. In non-pregnant group it was 4.12 
± 0.76 nmol/gHb with a range of 3.02 - 5.54, in pregnant its 
mean content was 6.90 ± 0.82 having the range of 5.52 - 8.03 
whereas in gestational diabetics the mean level was found to 
be 7.85 ± 0.92 which ranged from 6.25 to 10.36 nmol/gHb. 
Thus, the oxidative level in pregnant increased significantly 
(p < 0.001, t = -13.203) as compared to non-pregnant, and 
in gestational diabetics it also increased significantly (p = 
0.001, t = -3.968) as compared to pregnant patients. These 
are summarized in Figure 1.
The anti-oxidative status of these individuals was esti-
mated by evaluating the vitamins C, E and A levels. Vitamin 
C was found to be 54.26 ± 14.80 μmol/L in non-pregnant with 
individual content variation from 29.99 to 84.11 μmol/L. In 
pregnant patients, its levels were found to vary from 11.80 to 
49.54 with a mean value of 31.54 ± 11.07 μmol/L.  However, 
in gestational diabetics its mean value was estimated to be 
25.05 ± 7.63 μmol/L having individual value variations from 
8.67 to 36.86 μmol/L. There was a decline (p < 0.001, t = 
6.292) of vitamin C content in pregnant group as compared 
to non-pregnant. When gestational diabetics group was com-








Number of maternal 23 23 23
Maternal age (years) 27 ± 4 26 ± 5 28 ± 4 0.46 0.14
Gestational age (weeks) --- 35 ± 1.6 35 ± 2.1                 --- 1.0
Maternal hemoglobin 12 ± 2.4 11 ± 2.2 11 ± 1.4 0.15 1.0
BMI at delivery ( kg/m2 ) 20.1 ± 1.4 20.4 ± 2.6 21 ± 2.4 0.63 0.42
Birth weight (g) --- 2982 ± 389 3018 ± 423 --- 0.77
Values are expressed as mean ± SD; BMI - body mass index;  
P = Two tailed probability; P# = Comparison between NP - P; P# # = Comparison between P - GDM                                                   
Table 1. Clinical Profiles of the Patient Groups
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tively less (p = 0.025, t = 2.411). The overall alterations in 
vitamin C contents in these groups are shown in Figure 2. 
The estimation of vitamin E in non-pregnant group re-
vealed its level to be 16.19 ± 2.92 μmol/L with individual 
level variations range from 11.02 to 22.08 μmol/L. In preg-
nant group, the mean value was 17.74 ± 2.16 with individual 
levels ranging from 14.29 to 22.48 μmol/L whereas in ges-
tational diabetics the mean level was 13.21 ± 2.64 μmol/L 
of the individual values ranging from 9.32 to 18.98 μmol/L. 
This showed an insignificant increase (p = 0.09, t = -1.774) 
in vitamin E content during pregnancy when compared with 
non-pregnant group, however, the decline in vitamin E level 
was significant (p < 0.001, t = -5.793) in gestational diabetics 
as compared to normal pregnant group (Fig. 3). 
Vitamin A content in non-pregnant group was found to 
be 302.08 ± 35.48 μg/L with the individual contents varying 
Figure 3. Vitamin E contents in non-pregnant, pregnant, gesta-
tional diabetics.
Figure 2. Vitamin C contents in non-pregnant, pregnant, gesta-
tional diabetics.
Figure 4. Vitamin A contents in non-pregnant, pregnant, gesta-
tional diabetics.
Figure 1. MDA contents in non-pregnant, pregnant, gestational 
diabetics.
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from 225.63 to 343.79 μg/L. Its level in pregnant group was 
249.53 ± 49.00 μg/L with the variation of 158.68 - 324.22 
μg/L contents in the individual pregnant patient. In gesta-
tional diabetics, the mean value was found to be 221.50 ± 
26.44 having individual variation range of 167.65 - 271.84 
μg/L. Thus, there was significant (p = 0.002, t = 3.509) de-
crease of vitamin A contents in pregnant group in compari-
son to non-pregnant group whereas this decline was com-
paratively less (p = 0.012, t = 2.728) in gestational diabetics 
as compared to pregnant group. These changes have been 
depicted in Figure 4.
The osmotic fragility of the mixed population of red 
blood cells obtained from all the three groups of patients was 
measured by scoring hemolysis in hypo-osmolar solutions 
(0.10-0.90% NaCl). The osmotic fragility (O.F.) profile of 
pregnant and gestational diabetics showed shift to the right 
side which shows that O.F. got increased in both the cases. 
The concentrations of saline solution causing 50% of hemo-
lysis in all the three groups have been evaluated and desig-
nated as Mean Erythrocytes Fragility (MEF). In case of non-
pregnant group, it was found to be 0.61 ± 0.018 whereas in 
pregnant and gestational diabetics, these were 0.615 ± 0.016 
and 0.628 ± 0.012. The enhancement of MEF was insignifi-
cant (p = 0.325, t = -1.00) in case of pregnant compared to 
non-pregnant whereas in gestational diabetics the increase 
was found to be significant (p = 0.003, t = -3.12). The osmot-
ic fragility profiles of three groups are depicted in Figure 5.
Discussion
  
Gestational  diabetes  mellitus  is  a  heterogeneous  disorder 
characterized by intolerance to carbohydrates and hypergly-
cemia in varied degrees of intensity, with onset or first di-
agnosis during pregnancy. The pregnancy is a physiological 
situation of insulin resistance; therefore, it may be the first 
moment in a woman’s life to test her capacity to respond 
to a physiological stress and to detect those at greater risk 
of developing diabetes in the future. Direct measurement of 
free radicals is difficult due to their unstable and transient 
nature; therefore, the tendency of free radicals to cause lipid 
peroxidation has been used as an indirect measure. In the 
present study the marker of lipid peroxidation (MDA) was 
found to increase during the progression of normal pregnan-
cy. An increase of 67.5% MDA content in pregnant group 
as  compared  to  non-pregnant  group,  further  elevation  of 
13.8% in GDM-group as compared to pregnant group, and 
overall increase of 90.5% in GDM group in comparison with 
non-pregnant healthy group were observed. Such alteration 
suggests an easier membrane lipoperoxidability and, conse-
quently, easier membrane damage during diabetic gestation. 
In diabetes mellitus, increased blood glucose levels in-
duce oxidative stress. Possible source of oxidative stress and 
damage to protein in diabetes include free radicals generated 
by auto oxidation of unsaturated lipids in plasma and mem-
brane proteins [29]. Our observation of increased osmotic 
fragility followed by significant enhancement of MDA level 
in gestational diabetics (GDM) is in harmony with the report 
of Spickett et al [30]. Furthermore, increased osmotic fragil-
ity results from oxidative damage to the erythrocyte mem-
brane, causing a decrease in membrane fluidity and reducing 
its ability to withstand osmotic changes. We have previously 
reported increased osmotic fragility of diabetic erythrocytes 
which on insulin treatment gave normal osmotic fragility 
profile [17]. The main determination of in vitro hemolysis 
is the volume of the cell at any given time in relation to its 
maximal possible membrane surface area. In vitro osmotic 
fragility is dependent on: (1) the suspending medium, whose 
pH and tonicity are controlled in the osmotic fragility test; 
(2) total number of intracellular osmotically active constitu-
ents, which determine cell volume in any given external en-
vironment; and (3) the critical hemolytic volume, a complex 
parameter dependent on quantitative and qualitative factors 
associated with the membrane lipid and protein. Therefore, 
the important relationship determining osmotic fragility is 
the ratio of critical hemolytic volume to the internal osmotic 
contents of the red blood cell. Our results on the red cells 
contents of MDA in normal and GDM clearly showed a sig-
nificant change in their internal contents. Significant increase 
in the O.F. in GDM would ultimately results in decreased 
Figure 5. Osmotic fragility profiles of the erythrocytes of non-
pregnant, pregnant, gestational diabetics.
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deformability of their erythrocytes leading to their shortened 
lifespan. 
Vitamin E is a chain breaking antioxidant protecting the 
lipid phase of the cell from oxidative chain reactions [31, 
5] and is an important lipid-soluble antioxidant in human 
plasma. The antioxidant effect of tocopherols is mainly due 
to their ability to donate hydrogens from the phenolic ring of 
the molecule to lipid radicals [32]. A tocopheroxyl-radical is 
then formed that can be reduced back to tocopherol.
Antioxidant  vitamins,  with  the  ability  to  stabilize 
highly reactive free radicals, act as the first line of defense 
against free radical attack and lipid peroxidation. Vitamins 
E (α-tocopherol) and C, have differences in the contribution 
they make to antioxidant potential, as vitamin E is the major 
lipid soluble chain-breaking antioxidant in cell-membranes 
while vitamin C is an important aqueous phase antioxidant. 
Antioxidants may act synergistically, for instance, when vi-
tamin C regenerates α-tocopherol from the tocopherol radi-
cal, this ‘sacrificial’ antioxidant acts more by sparing vitamin 
E than by recycling. The important role of vitamin C in ges-
tational diabetes, suggests that changes in its concentration 
may influence susceptibility of vascular endothelium to oxy-
gen toxicity. Thus, our present study on vitamin C concentra-
tion may provide a means of assessing the total capacity of 
the chain-breaking antioxidants to prevent lipid peroxidation 
in plasma and it might be important to evaluate the effec-
tiveness of potential antioxidant defense systems in limiting 
scale. This study, further, provides evidence for the relation-
ship between plasma vitamin C levels during the pregnancy 
and gestational diabetes. Our results showed 53.8% decrease 
in vitamin C concentration in gestational diabetics as com-
pared to non-pregnant and 20.6% decrease as compared to 
normal healthy pregnant. Our observation of such significant 
decline in vitamin C concentration is consistent with the re-
ports [14, 15] but contrary to those [13, 9] who have reported 
no change in vitamin C contents in GDM.
Both vitamins C and E behave as scavengers of ROS and 
interestingly, our results showed an increase of 9.6% vitamin 
E level during pregnancy. During normal pregnancy, plasma 
vitamin E concentrations show a progressive elevation, what 
could be due to the gestational increase in circulating lipo-
proteins, the transporters of vitamin E.
However, its level declined to the extent of 25.5% in 
GDM in comparison to pregnant and 18.4% as compared to 
non-pregnant. Our finding on such significant decrease of vi-
tamin E in GDM is in harmony with those reported earlier 
[10, 11, 14] and contrary to others [8, 12] who have reported 
increase in vitamin E level during the development of GDM. 
Another antioxidant, vitamin A was also found to decrease 
in its contents significantly; 11.2% and 26.7% as compared 
to pregnant and non-pregnant respectively, which is conso-
nant with the report [10] but different from others [13] who 
reported no change in its level in GDM.
Thus, our findings indicate highly enhanced lipid per-
oxidation and significant depletion in antioxidant capacity 
during the development of gestational diabetes and these al-
terations are not the cause but the consequence of GDM. Our 
data reveal that antioxidant defense mechanisms might be 
impaired in patients with gestational diabetes. 
These variations suggest an easier membrane lipoper-
oxidability  and,  consequently,  an  easier  RBC  membrane 
damage resulting in their shortened life-span, during dia-
betic gestation. The increased oxidative stress we found in 
pregnant women with GDM should be monitored by strictly 
controlling blood glucose during pregnancy with stringent 
recommendations and perhaps antioxidant supplementation. 
However, further studies are warranted to examine a wider 
range of biochemical parameters to evaluate the potential 
risks of oxidative damage in GDM.
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